Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where ...

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

Market Domination co-host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute.

Tempus AI, Inc. (NASDAQ:TEM) focuses on building platforms for cardiology, oncology, infectious diseases, neuropsychiatry, and radiology. On May 7, analyst Daniel Brennan of TD Cowen maintained a ...

TD Cowen reiterated a “buy” rating and issued a $74.00 target price (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Wolfe Research cut shares of Tempus AI from ...

In addition to TD Cowen, Tempus AI, Inc. Class A also received a Buy from Needham’s Ryan MacDonald in a report issued yesterday. However, on April 14, Bank of America Securities maintained a ...

In the last three months, 9 analysts have published ratings on Tempus AI (NASDAQ:TEM), offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of ...

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs. Tempus will use its “vast ...

We may make money when you click on links to our partners. Learn More. Tempus AI (TEM) is gaining traction on Wall Street, with its stock rising by 40% so far this year as reported on March 17 ...

TD Cowen reiterated a “buy” rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Bank of America upped ...